"Nanomedicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).
| Descriptor ID |
D050997
|
| MeSH Number(s) |
H01.603.600 J01.897.115.625 J01.897.520.600.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nanomedicine".
Below are MeSH descriptors whose meaning is more specific than "Nanomedicine".
This graph shows the total number of publications written about "Nanomedicine" by people in this website by year, and whether "Nanomedicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 3 | 4 |
| 2014 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 2 | 3 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nanomedicine" by people in Profiles.
-
Ren J, Andrikopoulos N, Velonia K, Tang H, Cai R, Ding F, Ke PC, Chen C. Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine. J Am Chem Soc. 2022 06 01; 144(21):9184-9205.
-
Li Y, Tang H, Zhu H, Kakinen A, Wang D, Andrikopoulos N, Sun Y, Nandakumar A, Kwak E, Davis TP, Leong DT, Ding F, Ke PC. Ultrasmall Molybdenum Disulfide Quantum Dots Cage Alzheimer's Amyloid Beta to Restore Membrane Fluidity. ACS Appl Mater Interfaces. 2021 Jun 30; 13(25):29936-29948.
-
Ke PC, Pilkington EH, Sun Y, Javed I, Kakinen A, Peng G, Ding F, Davis TP. Mitigation of Amyloidosis with Nanomaterials. Adv Mater. 2020 May; 32(18):e1901690.
-
Gold MR, Reth MG. Antigen Receptor Function in the Context of the Nanoscale Organization of the B Cell Membrane. Annu Rev Immunol. 2019 04 26; 37:97-123.
-
Almekkawy M, Chen J, Ellis MD, Haemmerich D, Holmes DR, Linte CA, Panescu D, Pearce J, Prakash P, Zderic V. Therapeutic Systems and Technologies: State-of-the-Art Applications, Opportunities, and Challenges. IEEE Rev Biomed Eng. 2020; 13:325-339.
-
Broome AM. Preface. Adv Cancer Res. 2018; 139:xiii-xiv.
-
Alexis F, Anker JN. Theranostic nanotechnologies: moving beyond imaging drug localization? Ther Deliv. 2014 Feb; 5(2):97-100.
-
Moore T, Chen H, Morrison R, Wang F, Anker JN, Alexis F. Nanotechnologies for noninvasive measurement of drug release. Mol Pharm. 2014 Jan 06; 11(1):24-39.
-
Grandhi TS, Potta T, Taylor DJ, Tian Y, Johnson RH, Meldrum DR, Rege K. Sensitizing cancer cells to TRAIL-induced death by micellar delivery of mitoxantrone. Nanomedicine (Lond). 2014; 9(12):1775-88.
-
Xu W, Burke JF, Pilla S, Chen H, Jaskula-Sztul R, Gong S. Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy. Nanoscale. 2013 Oct 21; 5(20):9924-33.